162 results
Page 4 of 9
8-K/A
EX-99.4
jure2x1inpc
26 Jun 20
Other Events
5:08pm
8-K
EX-99.1
xx3nw
3 Jun 20
Regulation FD Disclosure
12:00am
8-K
EX-10.3
5qtlklw2v0rzjvh b2n
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-99.1
imytj
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-10.4
zq3lm xc87lqico5
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-4.1
ske2od6fe sv7qrg69j
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-14.1
77117og
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-10.2
tiqqamh4 t411b
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
DEFA14A
d7e7fruopw 8ewrl
18 May 20
Additional proxy soliciting materials
9:55pm
DEFM14A
puyc9im5 p3f6a9627eh
29 Apr 20
Proxy related to merger
3:20pm
PRER14A
33nau qz3711v
10 Apr 20
Preliminary revised proxy
4:38pm
8-K
xsq yja34mzwzobwwmil
9 Mar 20
Entry into a Material Definitive Agreement
12:00am
DEFA14A
tw2g wny8
9 Mar 20
Additional proxy soliciting materials
12:00am
PREM14A
6pvirmw17f7db xg7wj
6 Mar 20
Preliminary proxy related to merger
5:32pm
8-K
EX-99.1
nan5u24
5 Mar 20
Zafgen Reports Fourth Quarter and Full Year 2019 Financial Results
4:16pm